Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline G Fahey

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Cell|December 25, 2025
Targeting STING to generate therapeutic anti-tumor immunityCaroline G Fahey, Anthony F Cordova, Patrick C Gedeon, et al.
The EMBO Journal|May 16, 2024
Early-stage lung cancer is driven by a transitional cell state dependent on a KRAS-ITGA3-SRC axisAaron L Moye, Antonella Fm Dost, Robert Ietswaart, et al.
Cancer Discovery|January 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor ImmunityTetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Cancers modulate p53 truncal neoantigen display to evade T cell detectionKoji Haratani, Bruce Reinhold, Jonathan S Duke-Cohan, et al.
Nature Communications|May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancerZehua Li, Cong Fu, Kartik Sehgal, et al.
Cancer Research|July 22, 2020
BRG1 Loss Predisposes Lung Cancers to Replicative Stress and ATR DependencyManav Gupta, Carla P Concepcion, Caroline G Fahey, et al.
Cancer Cell|March 6, 2026
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancerMarco Campisi, Tatsuya Osaki, Ian Dryg, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Cell|December 25, 2025
Targeting STING to generate therapeutic anti-tumor immunityCaroline G Fahey, Anthony F Cordova, Patrick C Gedeon, et al.
The EMBO Journal|May 16, 2024
Early-stage lung cancer is driven by a transitional cell state dependent on a KRAS-ITGA3-SRC axisAaron L Moye, Antonella Fm Dost, Robert Ietswaart, et al.
Cancer Discovery|January 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor ImmunityTetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Cancers modulate p53 truncal neoantigen display to evade T cell detectionKoji Haratani, Bruce Reinhold, Jonathan S Duke-Cohan, et al.
Nature Communications|May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancerZehua Li, Cong Fu, Kartik Sehgal, et al.
Cancer Research|July 22, 2020
BRG1 Loss Predisposes Lung Cancers to Replicative Stress and ATR DependencyManav Gupta, Carla P Concepcion, Caroline G Fahey, et al.
Cancer Cell|March 6, 2026
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancerMarco Campisi, Tatsuya Osaki, Ian Dryg, et al.
Pageof 1